Guy Leverger Selected Research

Evans Syndrome

1/2022	Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden.
1/2022	Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias.
1/2019	Neurological Involvement in Childhood Evans Syndrome.
1/2017	Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.
12/2007	Rituximab therapy for childhood Evans syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy Leverger Research Topics

Disease

20	Leukemia 10/2022 - 01/2005
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2021 - 06/2002
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2021 - 01/2003
10	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 09/2011
7	Neoplasms (Cancer) 01/2018 - 05/2002
5	Invasive Fungal Infections 08/2022 - 12/2016
5	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 01/2015
5	Evans Syndrome 01/2022 - 12/2007
4	Cytopenia 01/2022 - 05/2018
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2021 - 07/2005
3	Infections 08/2022 - 01/2003
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 12/2016
3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2020 - 09/2015
3	Residual Neoplasm 01/2011 - 03/2006
3	Neutropenia 10/2006 - 01/2003
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 11/2009
2	Invasive Candidiasis 05/2020 - 09/2008
2	Rare Diseases (Rare Disease) 11/2019 - 10/2006
2	Mycoses (Diseases, Fungus) 01/2018 - 12/2016
2	Autoimmune Lymphoproliferative Syndrome 01/2018 - 09/2014
2	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2017 - 01/2005
2	Mucositis 12/2016 - 10/2006
2	Hematologic Neoplasms (Hematological Malignancy) 12/2016 - 04/2008
2	Thrombocytopenia (Thrombopenia) 09/2012 - 10/2006
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2007 - 01/2003
2	Fever (Fevers) 10/2006 - 03/2004
2	Chills 08/2005 - 01/2003
1	Aplastic Anemia (Anemia, Hypoplastic) 08/2022
1	Disease Progression 12/2020
1	X-linked sideroblastic anemia 11/2019
1	Deafness (Deaf Mutism) 11/2019
1	Pathologic Complete Response 12/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Acute Promyelocytic Leukemia 01/2018
1	Primary Immunodeficiency Diseases 01/2018
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2018

Drug/Important Bio-Agent (IBA)

6	Inosine Triphosphate (ITP)IBA 01/2022 - 01/2014
6	Biological ProductsIBA 02/2021 - 07/2005
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 01/2003
4	Pharmaceutical PreparationsIBA 10/2022 - 10/2006
4	Rituximab (Mabthera)FDA Link 01/2021 - 12/2007
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 09/2012
4	Core Binding Factors (Core-Binding Factor)IBA 12/2018 - 01/2016
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2009 - 01/2003
3	Imatinib Mesylate (Gleevec)FDA Link 08/2021 - 01/2009
3	Micafungin (FK463)FDA Link 05/2020 - 09/2008
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 02/2016
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 02/2016
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 05/2017
2	Interleukin-2 (IL2)IBA 12/2018 - 01/2016
2	Clofarabine (Clolar)FDA Link 01/2018 - 02/2016
2	AnthracyclinesIBA 01/2018 - 10/2009
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2018 - 03/2008
2	Thrombopoietin (c-mpl Ligand)IBA 12/2016 - 02/2014
2	EnzymesIBA 04/2013 - 02/2012
2	Vinblastine (Vinblastine Sulfate)FDA Link 09/2011 - 10/2009
2	ORALIT (ORS)IBA 07/2007 - 01/2005
2	InterferonsIBA 10/2006 - 08/2005
2	Gemtuzumab (Mylotarg)FDA Link 06/2006 - 03/2006
2	Colistin (Coly-Mycin)FDA Link 08/2005 - 01/2003
1	venetoclaxIBA 10/2022
1	Azacitidine (5 Azacytidine)FDA Link 10/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Growth Hormone (Somatotropin)IBA 02/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	Azathioprine (Imuran)FDA LinkGeneric 01/2021
1	Testosterone (Sustanon)FDA Link 01/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	Cladribine FDA LinkGeneric 12/2020
1	NucleosidesIBA 12/2020
1	EchinocandinsIBA 05/2020
1	Heme (Haem)IBA 11/2019
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 11/2019
1	IronIBA 11/2019
1	Thiamine (Aneurin)FDA Link 11/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	LipopolysaccharidesIBA 01/2018
1	telomerase RNA (bTR)IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	CholesterolIBA 01/2018
1	Polycomb Repressive Complex 2IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	CohesinsIBA 01/2018

Therapy/Procedure

15	Therapeutics 08/2022 - 06/2002
9	Hematopoietic Stem Cell Transplantation 09/2021 - 01/2005
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
4	Splenectomy 01/2022 - 11/2011
4	Transplantation 02/2021 - 01/2005
3	Salvage Therapy 10/2009 - 03/2008
2	Aftercare (After-Treatment) 01/2021 - 11/2009
2	Homologous Transplantation 05/2011 - 01/2005
1	Length of Stay 08/2022
1	Immunomodulation 01/2021
1	Emergency Treatment 01/2021